SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

Read more breaking news

 

 

Net earnings tumble at Akzo

16-Apr-2003

Akzo Nobel, Dutch pharmaceuticals, coatings and chemicals company, reports first quarter net earnings of €164 million, a considerable 30 per cent below the first quarter of 2002.

In presenting the report this week, Akzo Nobel's CFO Fritz Fröhlich said: "All groups were severely impacted by negative currency movements, especially the lower US dollar. Pension charges were higher. On top of that we experienced a significant increase in generic competition in our human healthcare business Organon.

The combined forces of these strong headwinds have triggered a 30 per cent decline against a very strong first quarter last year."

Moving quickly to counterbalance the weaker results, Akzo said on Tuesday that it is actively restructuring to bring costs back in line with its earnings developments.

"Coatings and Chemicals are, excluding the currency and pension effects, delivering improved operational performance. They are benefiting from the stringent cost saving and restructuring programmes we implemented," added Fröhlich.

Akzo warned that the outlook for the full year remains significantly below 2002.

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions